Claus Braestrup

Biography

Claus Braestrup was appointed Member of the Supervisory Board on 12 June 2013 and was re-elected as Member of the Supervisory Board by the Annual General Meeting 2014 in June 2014. During his career, he gained extensive experience from publicly traded international pharmaceutical companies as well as scientific and drug discovery qualifications. From 2003 to 2008, Dr Braestrup served as president and CEO at H. Lundbeck A/S, where he was head of research and development from 1998 to 2003. Previously, he served as head of pre-clinical drug research at Schering AG from 1994 to 1998, at Novo Nordisk A/S as president of the Diabetes Care Division (1993-1994), president of its CNS Division (1988-1993) and vice president of pharmaceutical research (1984-1988) and at Ferrosan A/S as scientist in drug discovery from 1978 to 1984. He serves as Chairman of the Board of Saniona AB and as Member of the Board of Bavarian Nordic A/S, Kastan ApS and Evolva SA. Dr Braestrup is a Danish national, born in 1945. Dr Braestrup holds a Master’s degree in Chemical Engineering and is Master of Science in Biochemistry. He is Doctor of Medical Science and former Adjunct Professor in Neuroscience at the University of Copenhagen.

Research Interest

Biochemistry